Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX) Q3 2024 Earnings Call Transcript November 5, 2024
Syndax Pharmaceuticals, Inc. beats earnings expectations. Reported EPS is $-0.98, expectations were $-1.13.
Operator: Good day, everyone, and welcome to the Syndax Third Quarter 2024 Earnings Conference Call. Today’s call is being recorded. All participants have been placed in a listen-only mode. You’ll have an opportunity to ask questions after today’s presentation. [Operator Instructions] At this...
